-
1
-
-
3042700885
-
Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-α and IL-6 production
-
Akaogi J., Yamada H., Kuroda Y., Nacionales D. C., Reeves W. H., Satoh M.: Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-α and IL-6 production. J. Leukoc. Biol., 2004;76:227-236
-
(2004)
J. Leukoc. Biol.
, vol.76
, pp. 227-236
-
-
Akaogi, J.1
Yamada, H.2
Kuroda, Y.3
Nacionales, D.C.4
Reeves, W.H.5
Satoh, M.6
-
2
-
-
80054022565
-
The pharmacological effect of BGC20-1531, a novel prostanoid EP4 receptor antagonist, in the prostaglandin E2 human model of headache
-
Antonova M., Wienecke T., Maubach K., Thomas E., Olesen J., Ashina M.: The pharmacological effect of BGC20-1531, a novel prostanoid EP4 receptor antagonist, in the prostaglandin E2 human model of headache. J. Headache Pain, 2011;12:551-559
-
(2011)
J. Headache Pain
, vol.12
, pp. 551-559
-
-
Antonova, M.1
Wienecke, T.2
Maubach, K.3
Thomas, E.4
Olesen, J.5
Ashina, M.6
-
3
-
-
33744831158
-
Prostaglandin E2 promotes cell survival of glomerular epithelial cells via the EP4 receptor
-
Aoudjit L., Potapov A., Takano T.: Prostaglandin E2 promotes cell survival of glomerular epithelial cells via the EP4 receptor. Am. J. Physiol. Renal Physiol., 2006;290:F1534-F1542
-
(2006)
Am. J. Physiol. Renal Physiol.
, vol.290
-
-
Aoudjit, L.1
Potapov, A.2
Takano, T.3
-
4
-
-
0029832749
-
Involvement of prostaglandins in the down-regulation of allergic plasma leakage observed in rats undergoing pleural eosinophilia
-
Bandeira-Melo C., Singh Y., Cordeiro R. S., e Silva P. M., Martins M. A.: Involvement of prostaglandins in the down-regulation of allergic plasma leakage observed in rats undergoing pleural eosinophilia. Br. J. Pharmacol., 1996;118:2192-2198
-
(1996)
Br. J. Pharmacol.
, vol.118
, pp. 2192-2198
-
-
Bandeira-Melo, C.1
Singh, Y.2
Cordeiro, R.S.3
Silva, P.M.4
Martins, M.A.5
-
5
-
-
0032504686
-
Cyclo-oxygenase-2 regulates inducible ICAM-1 and VCAM-1 expression in human vascular smooth muscle cells
-
Bishop-Bailey B., Burke-Gaffney A., Hellewell P. G., Pepper J. R., Mitchell J. A.: Cyclo-oxygenase-2 regulates inducible ICAM-1 and VCAM-1 expression in human vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 1998;249:44-47
-
(1998)
Biochem. Biophys. Res. Commun.
, vol.249
, pp. 44-47
-
-
Bishop-Bailey, B.1
Burke-Gaffney, A.2
Hellewell, P.G.3
Pepper, J.R.4
Mitchell, J.A.5
-
6
-
-
78650511351
-
A novel series of potent and selective EP4 receptor ligands: Facile modulation of agonism and antagonism
-
Boyd M. J., Berthelette C., Chiasson J. F., Clark P., Colucci J., Denis D., Han Y., Lévesque J. F., Mathieu M. C., Stocco R., Therien A., Rowland S., Wrona M., Xu D.: A novel series of potent and selective EP4 receptor ligands: facile modulation of agonism and antagonism. Bioorg. Med. Chem. Lett., 2011;21:484-487
-
(2011)
Bioorg. Med. Chem. Lett.
, vol.21
, pp. 484-487
-
-
Boyd, M.J.1
Berthelette, C.2
Chiasson, J.F.3
Clark, P.4
Colucci, J.5
Denis, D.6
Han, Y.7
Lévesque, J.F.8
Mathieu, M.C.9
Stocco, R.10
Therien, A.11
Rowland, S.12
Wrona, M.13
Xu, D.14
-
7
-
-
81555216781
-
EP4 receptor as a new target for bronchodilator therapy
-
Buckley J., Birrell M. A., Maher S. A., Nials A. T., Clarke D. L., Belvisi M. G.: EP4 receptor as a new target for bronchodilator therapy. Thorax, 2011;66:1029-1035
-
(2011)
Thorax
, vol.66
, pp. 1029-1035
-
-
Buckley, J.1
Birrell, M.A.2
Maher, S.A.3
Nials, A.T.4
Clarke, D.L.5
Belvisi, M.G.6
-
8
-
-
77951692935
-
A novel antagonist of the prostaglandin E2 EP4 receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models
-
Chen Q., Muramoto K., Masaaki N., Ding Y., Yang H., Mackey M., Li W., Inoue Y., Ackermann K., Shirota H., Matsumoto I., Spyvee M., Schiller S., Sumida T., Gusovsky F., Lamphier M.: A novel antagonist of the prostaglandin E2 EP4 receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models. Br. J. Pharmacol., 2010;160:292-310
-
(2010)
Br. J. Pharmacol.
, vol.160
, pp. 292-310
-
-
Chen, Q.1
Muramoto, K.2
Masaaki, N.3
Ding, Y.4
Yang, H.5
Mackey, M.6
Li, W.7
Inoue, Y.8
Ackermann, K.9
Shirota, H.10
Matsumoto, I.11
Spyvee, M.12
Schiller, S.13
Sumida, T.14
Gusovsky, F.15
Lamphier, M.16
-
9
-
-
0028183018
-
International Union of Pharmacology classfication of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes
-
Coleman R. A., Smith W. L., Narumiya S.: International Union of Pharmacology classfication of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev., 1994;46:205-229
-
(1994)
Pharmacol. Rev.
, vol.46
, pp. 205-229
-
-
Coleman, R.A.1
Smith, W.L.2
Narumiya, S.3
-
10
-
-
4944238567
-
EP4 prostanoid receptor-mediated vasodilation of human middle cerebral arteries
-
Davis R. J., Murdoch C. E., Ali M., Purbrick S., Ravid R., Baxter G. S., Tilford N., Sheldrick R. L., Clark K. L., Coleman R. A.: EP4 prostanoid receptor-mediated vasodilation of human middle cerebral arteries. Br. J. Pharmacol., 2004;141:580-585
-
(2004)
Br. J. Pharmacol.
, vol.141
, pp. 580-585
-
-
Davis, R.J.1
Murdoch, C.E.2
Ali, M.3
Purbrick, S.4
Ravid, R.5
Baxter, G.S.6
Tilford, N.7
Sheldrick, R.L.8
Clark, K.L.9
Coleman, R.A.10
-
11
-
-
77955464551
-
Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis
-
Esaki Y., Li Y., Sakata D., Yao C., Segi-Nishida E., Matsuoka T., Fukuda K., Narumiya S.: Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA, 2010;107:12233-12238
-
(2010)
Proc. Natl. Acad. Sci. USA
, vol.107
, pp. 12233-12238
-
-
Esaki, Y.1
Li, Y.2
Sakata, D.3
Yao, C.4
Segi-Nishida, E.5
Matsuoka, T.6
Fukuda, K.7
Narumiya, S.8
-
12
-
-
0442276338
-
Pharmacogenomics of immunosuppressive drug metabolism
-
Fredericks S., Holt D. W.: Pharmacogenomics of immunosuppressive drug metabolism. Curr. Opin. Nephrol. Hypertens., 2003;12:607-613
-
(2003)
Curr. Opin. Nephrol. Hypertens.
, vol.12
, pp. 607-613
-
-
Fredericks, S.1
Holt, D.W.2
-
13
-
-
21144456524
-
Involvement of prostaglandin receptors (EPR2-4) in in vivo immunosuppression of PGE2 in rat skin transplant model
-
Fujimoto Y., Iwagaki H., Ozaki M., Ogino T., Murata H., Sun D. S., Sadamori H., Takahashi H. K., Tanaka N., Yagi T.: Involvement of prostaglandin receptors (EPR2-4) in in vivo immunosuppression of PGE2 in rat skin transplant model. Int. Immunopharmacol., 2005;5:1131-1139
-
(2005)
Int. Immunopharmacol.
, vol.5
, pp. 1131-1139
-
-
Fujimoto, Y.1
Iwagaki, H.2
Ozaki, M.3
Ogino, T.4
Murata, H.5
Sun, D.S.6
Sadamori, H.7
Takahashi, H.K.8
Tanaka, N.9
Yagi, T.10
-
14
-
-
0032903965
-
Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation
-
Gauvreau G. M., Watson R. M., O'Byrne P. M.: Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation. Am. J. Respir. Crit. Care Med., 1999;159:31-36
-
(1999)
Am. J. Respir. Crit. Care Med.
, vol.159
, pp. 31-36
-
-
Gauvreau, G.M.1
Watson, R.M.2
O'Byrne, P.M.3
-
15
-
-
33846457039
-
EP4 mediates PGE2 dependent cell survival through the PI3 kinase/AKT pathway
-
George R. J., Sturmoski M. A., Anant S., Houchen C. W.: EP4 mediates PGE2 dependent cell survival through the PI3 kinase/AKT pathway. Prostaglandins Other Lipid Mediat., 2007;83:112-120
-
(2007)
Prostaglandins Other Lipid Mediat.
, vol.83
, pp. 112-120
-
-
George, R.J.1
Sturmoski, M.A.2
Anant, S.3
Houchen, C.W.4
-
16
-
-
0032034245
-
PGE2 inhibits IL-2 and IL-4-dependent proliferation of CTLL-2 and HT2 cells
-
Gurlo T., Huang W. W., von Grafenstein H.: PGE2 inhibits IL-2 and IL-4-dependent proliferation of CTLL-2 and HT2 cells. Cytokine, 1998;10:265-274
-
(1998)
Cytokine
, vol.10
, pp. 265-274
-
-
Gurlo, T.1
Huang, W.W.2
Von Grafenstein, H.3
-
17
-
-
0037666202
-
Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes
-
Harizi H., Grosset C., Gualde N.: Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes. J. Leukoc. Biol., 2003;73:756-763
-
(2003)
J. Leukoc. Biol.
, vol.73
, pp. 756-763
-
-
Harizi, H.1
Grosset, C.2
Gualde, N.3
-
18
-
-
38949099298
-
EP4 agonist inhibits lipopolysaccharide-induced mucus secretion in airway epithelial cells
-
Hattori R., Shimizu S., Majima Y., Shimizu T.: EP4 agonist inhibits lipopolysaccharide-induced mucus secretion in airway epithelial cells. Ann. Otol. Rhinol. Laryngol., 2008;117:51-58
-
(2008)
Ann. Otol. Rhinol. Laryngol.
, vol.117
, pp. 51-58
-
-
Hattori, R.1
Shimizu, S.2
Majima, Y.3
Shimizu, T.4
-
19
-
-
0016798106
-
Prostaglandin-induced enhancement of the in vitro anamnetic response
-
Herscowitz H. B., Stylos W. A.: Prostaglandin-induced enhancement of the in vitro anamnetic response. Prostaglandins, 1975;10:87-99
-
(1975)
Prostaglandins
, vol.10
, pp. 87-99
-
-
Herscowitz, H.B.1
Stylos, W.A.2
-
20
-
-
57749190751
-
Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury
-
Hishikari K., Suzuki J., Ogawa M., Isobe K., Takahashi T., Onishi M., Takayama K., Isobe M.: Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury. Cardiovasc. Res., 2009;81:123-132
-
(2009)
Cardiovasc. Res.
, vol.81
, pp. 123-132
-
-
Hishikari, K.1
Suzuki, J.2
Ogawa, M.3
Isobe, K.4
Takahashi, T.5
Onishi, M.6
Takayama, K.7
Isobe, M.8
-
21
-
-
0038306837
-
Prostaglandin E2 protects gastric mucosal cells from apoptosis via EP2 and EP4 receptor activation
-
Hoshino T., Tsutsumi S., Tomisato W., Hwang H. J., Tsuchiya T., Mizushima T.: Prostaglandin E2 protects gastric mucosal cells from apoptosis via EP2 and EP4 receptor activation. J. Biol. Chem., 2003;278:12752-12758
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 12752-12758
-
-
Hoshino, T.1
Tsutsumi, S.2
Tomisato, W.3
Hwang, H.J.4
Tsuchiya, T.5
Mizushima, T.6
-
22
-
-
34548150722
-
Prostaglandin E2 induces vascular relaxation by E-prostanoid 4 receptor-mediated activation of endothelial nitric oxide synthase
-
Hristovska A. M., Rasmussen L. E., Hansen P. B., Nielsen S. S., Nüsing R. M., Narumiya S., Vanhoutte P., Skott O., Jensen B. L.: Prostaglandin E2 induces vascular relaxation by E-prostanoid 4 receptor-mediated activation of endothelial nitric oxide synthase. Hypertension, 2007;50:525-530
-
(2007)
Hypertension
, vol.50
, pp. 525-530
-
-
Hristovska, A.M.1
Rasmussen, L.E.2
Hansen, P.B.3
Nielsen, S.S.4
Nüsing, R.M.5
Narumiya, S.6
Vanhoutte, P.7
Skott, O.8
Jensen, B.L.9
-
23
-
-
79551533370
-
PGE1 and PGE2 modify platelet function through different prostanoid receptors
-
Iyú D., Jüttner M., Glenn J. R., White A. E., Johnson A. J., Fox S. C., Heptinstall S.: PGE1 and PGE2 modify platelet function through different prostanoid receptors. Prostaglandins Other Lipid Mediat., 2011;94:9-16
-
(2011)
Prostaglandins Other Lipid Mediat.
, vol.94
, pp. 9-16
-
-
Iyú, D.1
Jüttner, M.2
Glenn, J.R.3
White, A.E.4
Johnson, A.J.5
Fox, S.C.6
Heptinstall, S.7
-
24
-
-
54249155141
-
Prostaglandin E2 regulates tumor angiogenesis in prostate cancer
-
Jain S., Chakraborty G., Raja R., Kale S., Kundu G. C.: Prostaglandin E2 regulates tumor angiogenesis in prostate cancer. Cancer Res., 2008;68:7750-7759
-
(2008)
Cancer Res.
, vol.68
, pp. 7750-7759
-
-
Jain, S.1
Chakraborty, G.2
Raja, R.3
Kale, S.4
Kundu, G.C.5
-
25
-
-
78649572788
-
Comparison of prostaglandin E2 receptor subtype 4 agonist and sulfasalazine in mouse colitis prevention and treatment
-
Jiang G. L., Im W. B., Donde Y., Wheeler L. A.: Comparison of prostaglandin E2 receptor subtype 4 agonist and sulfasalazine in mouse colitis prevention and treatment. J. Pharmacol. Exp. Ther., 2010;335:546-552
-
(2010)
J. Pharmacol. Exp. Ther.
, vol.335
, pp. 546-552
-
-
Jiang, G.L.1
Im, W.B.2
Donde, Y.3
Wheeler, L.A.4
-
26
-
-
33845889285
-
The prevention of colitis by E prostanoid receptor 4 agonist through enhancement of epithelium survival and regeneration
-
Jiang G. L., Nieves A., Im W. B., Old D. W., Dinh D. T., Wheeler L.: The prevention of colitis by E prostanoid receptor 4 agonist through enhancement of epithelium survival and regeneration. J. Pharmacol. Exp. Ther., 2007;320:22-28
-
(2007)
J. Pharmacol. Exp. Ther.
, vol.320
, pp. 22-28
-
-
Jiang, G.L.1
Nieves, A.2
Im, W.B.3
Old, D.W.4
Dinh, D.T.5
Wheeler, L.6
-
27
-
-
5644234190
-
Prostaglandin E2 and dexamethasone regulate eosinophil differentiation and survival through a nitric oxide-and CD95-dependent pathway
-
Jones C. P., Paula Neto H. A., Assreuy J., Vargaftig B. B., Gaspar Elsas M. I., Elsas P. X.: Prostaglandin E2 and dexamethasone regulate eosinophil differentiation and survival through a nitric oxide-and CD95-dependent pathway. Nitric Oxide, 2004;11:184-193
-
(2004)
Nitric Oxide
, vol.11
, pp. 184-193
-
-
Jones, C.P.1
Paula Neto, H.A.2
Assreuy, J.3
Vargaftig, B.B.4
Gaspar Elsas, M.I.5
Elsas, P.X.6
-
28
-
-
0036221333
-
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut
-
Kabashima K., Saji T., Murata T., Nagamachi M., Matsuoka T., Segi E., Tsuboi K., Sugimoto Y., Kobayashi T., Miyachi Y., Ichikawa A., Narumiya S.: The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J. Clin. Invest., 2002;109:883-893
-
(2002)
J. Clin. Invest.
, vol.109
, pp. 883-893
-
-
Kabashima, K.1
Saji, T.2
Murata, T.3
Nagamachi, M.4
Matsuoka, T.5
Segi, E.6
Tsuboi, K.7
Sugimoto, Y.8
Kobayashi, T.9
Miyachi, Y.10
Ichikawa, A.11
Narumiya, S.12
-
29
-
-
27644464641
-
IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes
-
Kanda N., Koike S., Watanabe S.: IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes. J. Allergy Clin. Immunol., 2005;116:1144-1150
-
(2005)
J. Allergy Clin. Immunol.
, vol.116
, pp. 1144-1150
-
-
Kanda, N.1
Koike, S.2
Watanabe, S.3
-
30
-
-
22844448233
-
Prostaglandin E2 receptor EP4 agonist induces Bcl-xL and independently activates proliferation signals in mouse primary hepatocytes
-
Kataoka K., Takikawa Y., Lin S. D., Suzuki K.: Prostaglandin E2 receptor EP4 agonist induces Bcl-xL and independently activates proliferation signals in mouse primary hepatocytes. J. Gastroenterol., 2005;40:610-616
-
(2005)
J. Gastroenterol.
, vol.40
, pp. 610-616
-
-
Kataoka, K.1
Takikawa, Y.2
Lin, S.D.3
Suzuki, K.4
-
31
-
-
34247338970
-
Osteopontin deficiency enhances anabolic action of EP4 agonist at a sub-optimal dose in bone
-
Kato N., Kitahara K., Rittling S. R., Nakashima K., Denhardt D. T., Kurosawa H., Ezura Y., Noda M.: Osteopontin deficiency enhances anabolic action of EP4 agonist at a sub-optimal dose in bone. J. Endocrinol., 2007;193:171-182
-
(2007)
J. Endocrinol.
, vol.193
, pp. 171-182
-
-
Kato, N.1
Kitahara, K.2
Rittling, S.R.3
Nakashima, K.4
Denhardt, D.T.5
Kurosawa, H.6
Ezura, Y.7
Noda, M.8
-
32
-
-
77954071532
-
Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function
-
Kim M., Jung M., Hong S. P., Jeon H., Kim M. J., Cho M. Y., Lee S. H., Man M. Q., Elias P. M., Choi E. H.: Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function. Exp. Dermatol., 2010;19:501-510
-
(2010)
Exp. Dermatol.
, vol.19
, pp. 501-510
-
-
Kim, M.1
Jung, M.2
Hong, S.P.3
Jeon, H.4
Kim, M.J.5
Cho, M.Y.6
Lee, S.H.7
Man, M.Q.8
Elias, P.M.9
Choi, E.H.10
-
33
-
-
24144452193
-
Significance and therapeutic potential of prostaglandin E2 receptor in hepatic ischemia/reperfusion injury in mice
-
Kuzumoto Y., Sho M., Ikeda N., Hamada K., Mizuno T., Akashi S., Tsurui Y., Kashizuka H., Nomi T., Kubo A., Kanehiro H., Nakajima Y.: Significance and therapeutic potential of prostaglandin E2 receptor in hepatic ischemia/reperfusion injury in mice. Hepatology, 2005;42:608-617
-
(2005)
Hepatology
, vol.42
, pp. 608-617
-
-
Kuzumoto, Y.1
Sho, M.2
Ikeda, N.3
Hamada, K.4
Mizuno, T.5
Akashi, S.6
Tsurui, Y.7
Kashizuka, H.8
Nomi, T.9
Kubo, A.10
Kanehiro, H.11
Nakajima, Y.12
-
34
-
-
0036006135
-
Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells
-
Kvirkvelia N., Vojnovic I., Warner T. D., Athie-Morales V., Free P., Rayment N., Chain B. M., Rademacher T. W., Lund T., Roitt I. M., Delves P. J.: Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells. Clin. Exp. Immunol., 2002;127:263-269
-
(2002)
Clin. Exp. Immunol.
, vol.127
, pp. 263-269
-
-
Kvirkvelia, N.1
Vojnovic, I.2
Warner, T.D.3
Athie-Morales, V.4
Free, P.5
Rayment, N.6
Chain, B.M.7
Rademacher, T.W.8
Lund, T.9
Roitt, I.M.10
Delves, P.J.11
-
35
-
-
4444271426
-
Mechanisms involved in prostaglandin E2-mediated neuroprotection against TNF-α: Possible involvement of multiple signal transduction and -catenin/T-cell factor
-
Lee E. O., Shin Y. J., Chong Y. H.: Mechanisms involved in prostaglandin E2-mediated neuroprotection against TNF-α: possible involvement of multiple signal transduction and -catenin/T-cell factor. J. Neuroimmunol., 2004;155:21-31
-
(2004)
J. Neuroimmunol.
, vol.155
, pp. 21-31
-
-
Lee, E.O.1
Shin, Y.J.2
Chong, Y.H.3
-
36
-
-
0036094625
-
Topical corticosteroid-induced adrenocortical insufficiency: Clinical implications
-
Levin C., Maibach H. I.: Topical corticosteroid-induced adrenocortical insufficiency: clinical implications. Am. J. Clin. Dermatol., 2002;3:141-147
-
(2002)
Am. J. Clin. Dermatol.
, vol.3
, pp. 141-147
-
-
Levin, C.1
Maibach, H.I.2
-
37
-
-
80555136833
-
Signaling via the prostaglandin E2 receptor EP4 exerts neuronal and vascular protection in a mouse model of cerebral ischemia
-
Liang X., Lin L., Woodling N. S., Wang Q., Anacker C., Pan T., Merchant M., Andreasson K.: Signaling via the prostaglandin E2 receptor EP4 exerts neuronal and vascular protection in a mouse model of cerebral ischemia. J. Clin. Invest., 2011;121:4362-4371
-
(2011)
J. Clin. Invest.
, vol.121
, pp. 4362-4371
-
-
Liang, X.1
Lin, L.2
Woodling, N.S.3
Wang, Q.4
Anacker, C.5
Pan, T.6
Merchant, M.7
Andreasson, K.8
-
38
-
-
68349097303
-
Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: Analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01)
-
Loong S. L., Hwang J. S., Li H. H., Wee J. T., Yap S. P., Chua M. L., Fong K. W., Tan T. W.: Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01). Radiat. Oncol., 2009;4:23
-
(2009)
Radiat. Oncol.
, vol.4
, pp. 23
-
-
Loong, S.L.1
Hwang, J.S.2
Li, H.H.3
Wee, J.T.4
Yap, S.P.5
Chua, M.L.6
Fong, K.W.7
Tan, T.W.8
-
39
-
-
80054735367
-
EP4 receptor stimulation down-regulates human eosinophil function
-
Luschnig-Schratl P., Sturm E. M., Konya V., Philipose S., Marsche G., Fröhlich E., Samberger C., Lang-Loidolt D., Gattenlöhner S., Lippe I. T., Peskar B. A., Schuligoi R., Heinemann A.: EP4 receptor stimulation down-regulates human eosinophil function. Cell. Mol. Life Sci., 2011;68:3573-3587
-
(2011)
Cell. Mol. Life Sci.
, vol.68
, pp. 3573-3587
-
-
Luschnig-Schratl, P.1
Sturm, E.M.2
Konya, V.3
Philipose, S.4
Marsche, G.5
Fröhlich, E.6
Samberger, C.7
Lang-Loidolt, D.8
Gattenlöhner, S.9
Lippe, I.T.10
Peskar, B.A.11
Schuligoi, R.12
Heinemann, A.13
-
40
-
-
0030776485
-
Characterization of the prostanoid receptor (s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-α generation
-
Meja K. K., Barnes P. J., Giembycz M. A.: Characterization of the prostanoid receptor (s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-α generation. Br. J. Pharmacol., 1997;122:149-157
-
(1997)
Br. J. Pharmacol.
, vol.122
, pp. 149-157
-
-
Meja, K.K.1
Barnes, P.J.2
Giembycz, M.A.3
-
41
-
-
0036707524
-
Characterization of PGE2 receptor subtypes in human eosinophils
-
Mita H., Hasegawa M., Higashi N., Akiyama K.: Characterization of PGE2 receptor subtypes in human eosinophils. J. Allergy Clin. Immunol., 2002;110:457-459
-
(2002)
J. Allergy Clin. Immunol.
, vol.110
, pp. 457-459
-
-
Mita, H.1
Hasegawa, M.2
Higashi, N.3
Akiyama, K.4
-
42
-
-
77950646755
-
Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: A randomized phase II, placebo-controlled trial
-
Nakase H., Fujiyama Y., Oshitani N., Oga T., Nonomura K., Matsuoka T., Esaki Y., Murayama T., Teramukai S., Chiba T., Narumiya S.: Effect of EP4 agonist (ONO-4819CD) for patients with mild to moderate ulcerative colitis refractory to 5-aminosalicylates: a randomized phase II, placebo-controlled trial. Infamm. Bowel Dis., 2010;16:731-733
-
(2010)
Infamm. Bowel Dis.
, vol.16
, pp. 731-733
-
-
Nakase, H.1
Fujiyama, Y.2
Oshitani, N.3
Oga, T.4
Nonomura, K.5
Matsuoka, T.6
Esaki, Y.7
Murayama, T.8
Teramukai, S.9
Chiba, T.10
Narumiya, S.11
-
43
-
-
0034783581
-
Receptors for prostaglandin E (2) that regulate cellular immune responses in the mouse
-
Nataraj C., Thomas D. W., Tilley S. L., Nguyen M. T., Mannon R., Koller B. H., Coffman T. M.: Receptors for prostaglandin E (2) that regulate cellular immune responses in the mouse. J. Clin. Invest., 2001;108:1229-1235
-
(2001)
J. Clin. Invest.
, vol.108
, pp. 1229-1235
-
-
Nataraj, C.1
Thomas, D.W.2
Tilley, S.L.3
Nguyen, M.T.4
Mannon, R.5
Koller, B.H.6
Coffman, T.M.7
-
44
-
-
0036422957
-
Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: Colitis suppression by a selective agonist, ONO-AE1-329
-
Nitta M., Hirata I., Toshina K., Murano M., Maemura K., Hamamoto N., Sasaki S., Yamauchi H., Katsu K.: Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist, ONO-AE1-329. Scand. J. Immunol., 2002;56:66-75
-
(2002)
Scand. J. Immunol.
, vol.56
, pp. 66-75
-
-
Nitta, M.1
Hirata, I.2
Toshina, K.3
Murano, M.4
Maemura, K.5
Hamamoto, N.6
Sasaki, S.7
Yamauchi, H.8
Katsu, K.9
-
45
-
-
33845441547
-
Protective effect of prostaglandin E2 receptors EP2 and EP4 in alloimmune response in vivo
-
Nomi T., Sho M., Akahori T., Kanehiro H., Nakajima Y.: Protective effect of prostaglandin E2 receptors EP2 and EP4 in alloimmune response in vivo. Transplant. Proc., 2006;38:3209-3210
-
(2006)
Transplant. Proc.
, vol.38
, pp. 3209-3210
-
-
Nomi, T.1
Sho, M.2
Akahori, T.3
Kanehiro, H.4
Nakajima, Y.5
-
46
-
-
67649610602
-
The mechanism of anti-inflammatory effects of prostaglandin E2 receptor 4 activation in murine cardiac transplantation
-
Ogawa M., Suzuki J., Kosuge H., Takayama K., Nagai R., Isobe M.: The mechanism of anti-inflammatory effects of prostaglandin E2 receptor 4 activation in murine cardiac transplantation. Transplantation, 2009;87:1645-1653
-
(2009)
Transplantation
, vol.87
, pp. 1645-1653
-
-
Ogawa, M.1
Suzuki, J.2
Kosuge, H.3
Takayama, K.4
Nagai, R.5
Isobe, M.6
-
47
-
-
33745215097
-
E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2
-
Okano M., Sugata Y., Fujiwara T., Matsumoto R., Nishibori M., Shimizu K., Maeda M., Kimura Y., Kariya S., Hattori H., Yokoyama M., Kino K., Nishizaki K.: E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2. Immunology, 2006;118:343-352
-
(2006)
Immunology
, vol.118
, pp. 343-352
-
-
Okano, M.1
Sugata, Y.2
Fujiwara, T.3
Matsumoto, R.4
Nishibori, M.5
Shimizu, K.6
Maeda, M.7
Kimura, Y.8
Kariya, S.9
Hattori, H.10
Yokoyama, M.11
Kino, K.12
Nishizaki, K.13
-
48
-
-
43949117744
-
Effects of the selective EP4 antagonist, CJ-023, 423 on chronic infammation and bone destruction in rat adjuvant-induced arthritis
-
Okumura T., Murata Y., Taniguchi K., Murase A., Nii A.: Effects of the selective EP4 antagonist, CJ-023, 423 on chronic infammation and bone destruction in rat adjuvant-induced arthritis. J. Pharm. Pharmacol., 2008;60:723-730
-
(2008)
J. Pharm. Pharmacol.
, vol.60
, pp. 723-730
-
-
Okumura, T.1
Murata, Y.2
Taniguchi, K.3
Murase, A.4
Nii, A.5
-
49
-
-
0036303292
-
Effects of a novel selective agonist for prostaglandin receptor subtype EP4 on hyperalgesia and inflammation in monoarthritic model
-
Omote K., Kawamata T., Nakayama Y., Yamamoto H., Kawamata M., Namiki A.: Effects of a novel selective agonist for prostaglandin receptor subtype EP4 on hyperalgesia and inflammation in monoarthritic model. Anesthesiology, 2002;97:170-176
-
(2002)
Anesthesiology
, vol.97
, pp. 170-176
-
-
Omote, K.1
Kawamata, T.2
Nakayama, Y.3
Yamamoto, H.4
Kawamata, M.5
Namiki, A.6
-
50
-
-
0037090451
-
Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice
-
Peebles R. S. Jr., Hashimoto K., Morrow J. D., Dworski R., Collins R. D., Hashimoto Y., Christman J. W., Kang K. H., Jarzecka K., Furlong J., Mitchell D. B., Talati M., Graham B. S., Sheller J. R.: Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice. Am. J. Respir. Crit. Care Med., 2002;165:1154-1160
-
(2002)
Am. J. Respir. Crit. Care Med.
, vol.165
, pp. 1154-1160
-
-
Peebles Jr., R.S.1
Hashimoto, K.2
Morrow, J.D.3
Dworski, R.4
Collins, R.D.5
Hashimoto, Y.6
Christman, J.W.7
Kang, K.H.8
Jarzecka, K.9
Furlong, J.10
Mitchell, D.B.11
Talati, M.12
Graham, B.S.13
Sheller, J.R.14
-
51
-
-
78650415305
-
The prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formation
-
Philipose S., Konya V., Sreckovic I., Marsche G., Lippe I. T., Peskar B. A., Heinemann A., Schuligoi R.: The prostaglandin E2 receptor EP4 is expressed by human platelets and potently inhibits platelet aggregation and thrombus formation. Arterioscler. Thromb. Vasc. Biol., 2010;30:2416-2423
-
(2010)
Arterioscler. Thromb. Vasc. Biol.
, vol.30
, pp. 2416-2423
-
-
Philipose, S.1
Konya, V.2
Sreckovic, I.3
Marsche, G.4
Lippe, I.T.5
Peskar, B.A.6
Heinemann, A.7
Schuligoi, R.8
-
52
-
-
34447135497
-
Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo
-
Rao R., Redha R., Macias-Perez I., Su Y., Hao C., Zent R., Breyer M. D., Pozzi A.: Prostaglandin E2-EP4 receptor promotes endothelial cell migration via ERK activation and angiogenesis in vivo. J. Biol. Chem., 2007;282:16959-16968
-
(2007)
J. Biol. Chem.
, vol.282
, pp. 16959-16968
-
-
Rao, R.1
Redha, R.2
Macias-Perez, I.3
Su, Y.4
Hao, C.5
Zent, R.6
Breyer, M.D.7
Pozzi, A.8
-
53
-
-
0028868941
-
Cyclosporine-induced renal dysfunction in experimental animals and humans
-
Remuzzi G., Perico N.: Cyclosporine-induced renal dysfunction in experimental animals and humans. Kidney Int. Suppl., 1995;52:S70-S74
-
(1995)
Kidney Int. Suppl.
, vol.52
-
-
Remuzzi, G.1
Perico, N.2
-
54
-
-
77749343043
-
Gastrointestinal and liver adverse effects of drugs used for treating IBD
-
Rogler G.: Gastrointestinal and liver adverse effects of drugs used for treating IBD. Best. Pract. Res. Clin. Gastroenterol., 2010;24, 157-165
-
(2010)
Best. Pract. Res. Clin. Gastroenterol.
, vol.24
, pp. 157-165
-
-
Rogler, G.1
-
55
-
-
33744804337
-
Cyclooxygenase-2 inhibitors: A painful lesson
-
Sanghi S., MacLaughlin E. J., Jewell C. W., Chaffer S., Naus P. J., Watson L. E., Dostal D. E.: Cyclooxygenase-2 inhibitors: a painful lesson. Cardiovasc. Hematol. Disord. Drug Targets, 2006;6:85-100
-
(2006)
Cardiovasc. Hematol. Disord. Drug Targets
, vol.6
, pp. 85-100
-
-
Sanghi, S.1
MacLaughlin, E.J.2
Jewell, C.W.3
Chaffer, S.4
Naus, P.J.5
Watson, L.E.6
Dostal, D.E.7
-
56
-
-
2442537090
-
A prostanoid receptor EP4 agonist enhances ectopic bone formation induced by recombinant human bone morphogenetic protein-2
-
Sasaoka R., Terai H., Toyoda H., Imai Y., Sugama R., Takaoka K.: A prostanoid receptor EP4 agonist enhances ectopic bone formation induced by recombinant human bone morphogenetic protein-2. Biochem. Biophys. Res. Commun., 2004;318:704-709
-
(2004)
Biochem. Biophys. Res. Commun.
, vol.318
, pp. 704-709
-
-
Sasaoka, R.1
Terai, H.2
Toyoda, H.3
Imai, Y.4
Sugama, R.5
Takaoka, K.6
-
57
-
-
77953638394
-
The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity
-
Shi J., Johansson J., Woodling N. S., Wang Q., Montine T. J., Andreasson K.: The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity. J. Immunol., 2010;184:7207-7218
-
(2010)
J. Immunol.
, vol.184
, pp. 7207-7218
-
-
Shi, J.1
Johansson, J.2
Woodling, N.S.3
Wang, Q.4
Montine, T.J.5
Andreasson, K.6
-
58
-
-
77954652338
-
PGE2 is a UVR-inducible autocrine factor for human melanocytes that stimulates tyrosinase activation
-
Starner R. J., McClelland L., Abdel-Malek Z., Fricke A., Scott G.: PGE2 is a UVR-inducible autocrine factor for human melanocytes that stimulates tyrosinase activation. Exp. Dermatol., 2010;19:682-684
-
(2010)
Exp. Dermatol.
, vol.19
, pp. 682-684
-
-
Starner, R.J.1
McClelland, L.2
Abdel-Malek, Z.3
Fricke, A.4
Scott, G.5
-
59
-
-
58149179176
-
Prostaglandin E2 inhibits eosinophil trafficking through E-prostanoid 2 receptors
-
Sturm E. M., Schratl P., Schuligoi R., Konya V., Sturm G. J., Lippe I. T., Peskar B. A., Heinemann A.: Prostaglandin E2 inhibits eosinophil trafficking through E-prostanoid 2 receptors. J. Immunol., 2008;181:7273-7283
-
(2008)
J. Immunol.
, vol.181
, pp. 7273-7283
-
-
Sturm, E.M.1
Schratl, P.2
Schuligoi, R.3
Konya, V.4
Sturm, G.J.5
Lippe, I.T.6
Peskar, B.A.7
Heinemann, A.8
-
60
-
-
33745622119
-
COX-1 inhibition enhances scratching behavior in NC/Nga mice with atopic dermatitis
-
Sugimoto M., Arai I., Futaki N., Hashimoto Y., Honma Y., Nakaike S.: COX-1 inhibition enhances scratching behavior in NC/Nga mice with atopic dermatitis. Exp. Dermatol., 2006;15:582-588
-
(2006)
Exp. Dermatol.
, vol.15
, pp. 582-588
-
-
Sugimoto, M.1
Arai, I.2
Futaki, N.3
Hashimoto, Y.4
Honma, Y.5
Nakaike, S.6
-
61
-
-
38149119628
-
Antiinflammatory activity of sertaconazole nitrate is mediated via activation of a p38-COX-2-PGE2 pathway
-
Sur R., Babad J. M., Garay M., Liebel F. T., Southall M. D.: Antiinflammatory activity of sertaconazole nitrate is mediated via activation of a p38-COX-2-PGE2 pathway. J. Invest. Dermatol., 2008;128:336-344
-
(2008)
J. Invest. Dermatol.
, vol.128
, pp. 336-344
-
-
Sur, R.1
Babad, J.M.2
Garay, M.3
Liebel, F.T.4
Southall, M.D.5
-
62
-
-
34347380335
-
Roles of cyclooxygenase-2 and prostaglandin E receptors in gastric mucosal defense in Helicobacter pylori-infected mice
-
Taira K., Watanabe T., Tanigawa T., Shiba M., Tominaga K., Fujiwara Y., Oshitani N., Higuchi K., Arakawa T.: Roles of cyclooxygenase-2 and prostaglandin E receptors in gastric mucosal defense in Helicobacter pylori-infected mice. Inflammopharmacology, 2007;15:132-138
-
(2007)
Inflammopharmacology
, vol.15
, pp. 132-138
-
-
Taira, K.1
Watanabe, T.2
Tanigawa, T.3
Shiba, M.4
Tominaga, K.5
Fujiwara, Y.6
Oshitani, N.7
Higuchi, K.8
Arakawa, T.9
-
63
-
-
0036568949
-
Prostaglandin E2 inhibits IL-18-induced ICAM-1 and B7.2 expression through EP2/EP4 receptors in human peripheral blood mononuclear cells
-
Takahashi H. K., Iwagaki H., Yoshino T., Mori S., Morichika T., Itoh H., Yokoyama M., Kubo S., Kondo E., Akagi T., Tanaka N., Nishibori M.: Prostaglandin E2 inhibits IL-18-induced ICAM-1 and B7.2 expression through EP2/EP4 receptors in human peripheral blood mononuclear cells. J. Immunol., 2002;168:4446-4454
-
(2002)
J. Immunol.
, vol.168
, pp. 4446-4454
-
-
Takahashi, H.K.1
Iwagaki, H.2
Yoshino, T.3
Mori, S.4
Morichika, T.5
Itoh, H.6
Yokoyama, M.7
Kubo, S.8
Kondo, E.9
Akagi, T.10
Tanaka, N.11
Nishibori, M.12
-
64
-
-
20944447139
-
Prostaglandin E1-initiated immune regulation during human mixed lymphocyte reaction
-
Takahashi H. K., Xue D., Iwagaki H., Tamura R., Katsuno G., Yagi T., Yoshino T., Mori S., Nishibori M., Tanaka N.: Prostaglandin E1-initiated immune regulation during human mixed lymphocyte reaction. Clin. Immunol., 2005;115:85-92
-
(2005)
Clin. Immunol.
, vol.115
, pp. 85-92
-
-
Takahashi, H.K.1
Xue, D.2
Iwagaki, H.3
Tamura, R.4
Katsuno, G.5
Yagi, T.6
Yoshino, T.7
Mori, S.8
Nishibori, M.9
Tanaka, N.10
-
65
-
-
77951586516
-
Endogenous prostaglandin E2 accelerates healing of indomethacin-induced small intestinal lesions through upregulation of vascular endothelial growth factor expression by activation of EP4 receptors
-
Takeuchi K., Tanigami M., Amagase K., Ochi A., Okuda S., Hatazawa R.: Endogenous prostaglandin E2 accelerates healing of indomethacin-induced small intestinal lesions through upregulation of vascular endothelial growth factor expression by activation of EP4 receptors. J. Gastroenterol. Hepatol., 2010;25(Suppl.1):S67-S74
-
(2010)
J. Gastroenterol. Hepatol.
, vol.25
, Issue.SUPPL. 1
-
-
Takeuchi, K.1
Tanigami, M.2
Amagase, K.3
Ochi, A.4
Okuda, S.5
Hatazawa, R.6
-
66
-
-
33846427739
-
Prostaglandin E receptor EP4 antagonist suppresses osteolysis due to bone metastasis of mouse malignant melanoma cells
-
Takita M., Inada M., Maruyama T., Miyaura C.: Prostaglandin E receptor EP4 antagonist suppresses osteolysis due to bone metastasis of mouse malignant melanoma cells. FEBS Lett., 2007;581:565-571
-
(2007)
FEBS Lett.
, vol.581
, pp. 565-571
-
-
Takita, M.1
Inada, M.2
Maruyama, T.3
Miyaura, C.4
-
67
-
-
84857053651
-
Anti-inflammation therapy by activation of prostaglandin EP4 receptor in cardiovascular and other inflammatory diseases
-
Tang E. H., Libby P., Vanhoutte P. M., Xu A.: Anti-inflammation therapy by activation of prostaglandin EP4 receptor in cardiovascular and other inflammatory diseases. J. Cardiovasc. Pharmacol., 2012;59:116-123
-
(2012)
J. Cardiovasc. Pharmacol.
, vol.59
, pp. 116-123
-
-
Tang, E.H.1
Libby, P.2
Vanhoutte, P.M.3
Xu, A.4
-
68
-
-
0034737777
-
Biphasic actions of prostaglandin E (2) on the renal afferent arteriole: Role of EP (3) and EP (4) receptors
-
Tang L., Loutzenhiser K., Loutzenhiser R.: Biphasic actions of prostaglandin E (2) on the renal afferent arteriole: role of EP (3) and EP (4) receptors. Circ. Res., 2000;86:663-670
-
(2000)
Circ. Res.
, vol.86
, pp. 663-670
-
-
Tang, L.1
Loutzenhiser, K.2
Loutzenhiser, R.3
-
69
-
-
0029045083
-
Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation
-
Textor S. C., Burnett J. C. Jr., Romero J. C., Canzanello V. J., Taler S. J., Wiesner R., Porayko M., Krom R., Gores G., Hay E.: Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation. Kidney Int., 1995;47:1426-1433
-
(1995)
Kidney Int.
, vol.47
, pp. 1426-1433
-
-
Textor, S.C.1
Burnett Jr., J.C.2
Romero, J.C.3
Canzanello, V.J.4
Taler, S.J.5
Wiesner, R.6
Porayko, M.7
Krom, R.8
Gores, G.9
Hay, E.10
-
70
-
-
0036319489
-
Inhibition of cyclo-oxigenase-2 activity does not abolish the anabolic effect of prostaglandin E2 in vivo or in vitro
-
Weinreb M., Kelner A., Keila S.: Inhibition of cyclo-oxigenase-2 activity does not abolish the anabolic effect of prostaglandin E2 in vivo or in vitro. J. Endocrinol., 2002;174:127-135
-
(2002)
J. Endocrinol.
, vol.174
, pp. 127-135
-
-
Weinreb, M.1
Kelner, A.2
Keila, S.3
-
71
-
-
33747827859
-
Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity
-
Weinreb M., Shamir D., Machwate M., Rodan G. A., Harada S., Keila S.: Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity. Prostaglandins Leukot. Essent. Fatty Acids, 2006;75:81-90
-
(2006)
Prostaglandins Leukot. Essent. Fatty Acids
, vol.75
, pp. 81-90
-
-
Weinreb, M.1
Shamir, D.2
Machwate, M.3
Rodan, G.A.4
Harada, S.5
Keila, S.6
-
72
-
-
27744477634
-
Prostanoids as friends, not foes: Further evidence from the interference by cycloxygenase-inhibitory drugs when inducing tolerance to experimental arthritigens in rats
-
Whitehouse M. W.: Prostanoids as friends, not foes: further evidence from the interference by cycloxygenase-inhibitory drugs when inducing tolerance to experimental arthritigens in rats. Inflammopharmacology, 2005;12:481-492
-
(2005)
Inflammopharmacology
, vol.12
, pp. 481-492
-
-
Whitehouse, M.W.1
-
73
-
-
51549117698
-
Prostacyclin (epoprostenol) induces headache in healthy subjects
-
Wienecke T., Olesen J., Oturai P. S., Ashina M.: Prostacyclin (epoprostenol) induces headache in healthy subjects. Pain, 2008;139:106-116
-
(2008)
Pain
, vol.139
, pp. 106-116
-
-
Wienecke, T.1
Olesen, J.2
Oturai, P.S.3
Ashina, M.4
-
74
-
-
63849165405
-
Prostaglandin E2 (PGE2) induces headache in healthy subjects
-
Wienecke T., Olesen J., Oturai P. S., Ashina M.: Prostaglandin E2 (PGE2) induces headache in healthy subjects. Cephalalgia, 2009;29:509-519
-
(2009)
Cephalalgia
, vol.29
, pp. 509-519
-
-
Wienecke, T.1
Olesen, J.2
Oturai, P.S.3
Ashina, M.4
-
75
-
-
2542501367
-
Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4
-
Xiao C. Y., Yuhki K., Hara A., Fujino T., Kuriyama S., Yamada T., Takayama K., Takahata O., Karibe H., Taniguchi T., Narumiya S., Ushikubi F.: Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4. Circulation, 2004;109:2462-2468
-
(2004)
Circulation
, vol.109
, pp. 2462-2468
-
-
Xiao, C.Y.1
Yuhki, K.2
Hara, A.3
Fujino, T.4
Kuriyama, S.5
Yamada, T.6
Takayama, K.7
Takahata, O.8
Karibe, H.9
Taniguchi, T.10
Narumiya, S.11
Ushikubi, F.12
-
76
-
-
0034638635
-
Prostaglandin E2 receptors, EP2 and EP4, differentially modulate TNF-alpha and IL-6 production induced by lipopolysaccharide in mouse peritoneal neutrophils
-
Yamane H., Sugimoto Y., Tanaka S., Ichikawa A.: Prostaglandin E2 receptors, EP2 and EP4, differentially modulate TNF-alpha and IL-6 production induced by lipopolysaccharide in mouse peritoneal neutrophils. Biochem. Biophys. Res. Commun., 2000;278:224-228
-
(2000)
Biochem. Biophys. Res. Commun.
, vol.278
, pp. 224-228
-
-
Yamane, H.1
Sugimoto, Y.2
Tanaka, S.3
Ichikawa, A.4
-
77
-
-
0037007077
-
Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation
-
Yoshida K., Oida H., Kobayashi T., Maruyama T., Tanaka M., Katayama T., Yamaguchi K., Segi E., Tsuboyama T., Matsushita M., Ito K., Ito Y., Sugimoto Y., Ushikubi F., Ohuchida S., Kondo K., Nakamura T., Narumiya S.: Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc. Natl. Acad. Sci. USA, 2002;99:4580-4585
-
(2002)
Proc. Natl. Acad. Sci. USA
, vol.99
, pp. 4580-4585
-
-
Yoshida, K.1
Oida, H.2
Kobayashi, T.3
Maruyama, T.4
Tanaka, M.5
Katayama, T.6
Yamaguchi, K.7
Segi, E.8
Tsuboyama, T.9
Matsushita, M.10
Ito, K.11
Ito, Y.12
Sugimoto, Y.13
Ushikubi, F.14
Ohuchida, S.15
Kondo, K.16
Nakamura, T.17
Narumiya, S.18
-
78
-
-
0017092509
-
The regulation of the immune response to T-independent antigens by prostaglandins and B cells
-
Zimecki M., Webb D. R.: The regulation of the immune response to T-independent antigens by prostaglandins and B cells. J. Immunol., 1976;117:2158-2164
-
(1976)
J. Immunol.
, vol.117
, pp. 2158-2164
-
-
Zimecki, M.1
Webb, D.R.2
-
79
-
-
0019143985
-
The regulation of the immune response to polyvinylpyrollidone: Antigen induced changes in prostaglandin and cyclic nucleotide levels
-
Zimecki M., Webb D. R., Rogers T. J.: The regulation of the immune response to polyvinylpyrollidone: antigen induced changes in prostaglandin and cyclic nucleotide levels. Arch. Immunol. Ther. Exp., 1980;28:179-197
-
(1980)
Arch. Immunol. Ther. Exp.
, vol.28
, pp. 179-197
-
-
Zimecki, M.1
Webb, D.R.2
Rogers, T.J.3
|